hirudin
Biologicalexperimental
Hirudin is a naturally occurring peptide in the salivary glands of blood-sucking leeches that has a blood anticoagulant property. This is essential for the leeches' habit of feeding on blood, since it keeps a host's blood flowing after the worm's initial puncture of the skin. — Wikipedia
Clinical trial activity
3 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
2
Earliest trial started Oct 1, 2013 (NCT01960569)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 3 Sponsor(trial)
Indications
Approved for
Mechanism of action
- ThrombinINHIBITOR
F2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaHirudin ↗
Also known as
- hirudin
- hirudin
- thrombexx
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05847205 | Phase 4 | Nov 24, 2022 | Alexandria University, MinaPharm Pharmaceuticals |
| NCT02181361 | Phase 3 | Jun 1, 2014 | Jiao Tong University, People's Liberation Army of China, Shaanxi Provincial People's Hospital |
| NCT01960569 | Phase 4 | Oct 1, 2013 | MinaPharm Pharmaceuticals, October 6 University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| MinaPharm Pharmaceuticals | For profit | 2 | 2 | 1 | 2013 |
| Alexandria University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Jiao Tong University | Academic/Hospital | 1 | 0 | 1 | 2014 |
| October 6 University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| People's Liberation Army of China | Government | 1 | 1 | 1 | 2014 |
| Shaanxi Provincial People's Hospital | Academic/Hospital | 1 | 0 | 1 | 2014 |
6 organizations
Page 1 / 1